Generic Drugs

Nov 08, 2018
By Pharmaceutical Technology Editors
Permission from the United Kingdom's Supreme Court has been granted to the UK BioIndustry Association, allowing it to intervene in a dosage regimen patent case.
Nov 02, 2018
By Pharmaceutical Technology Editors
Irish manufacturer of generic medicines for both human and animal health, Chanelle Pharma, has been named as Pharma Industry Company of the Year 2018.
Oct 19, 2018
Pharmaceutical Technology
To achieve a more dynamic marketplace, FDA is issuing guidance documents and targeted advisories to support R&D on complex generics and combination products.
Oct 17, 2018
By Pharmaceutical Technology Editors
Cambrex will create a new center of excellence for API process development and clinical supply at its High Point, NC facility and expand its API manufacturing facility in Italy.
Sep 07, 2018
More than 120 healthcare organizations plan to bring competition to generic drug market.
Sep 06, 2018
By Pharmaceutical Technology Editors
Novartis will sell selected portions of its Sandoz United States portfolio to Aurobindo Pharma USA for $900 million in cash, plus $100 million in potential earn-outs.
Sep 04, 2018
By Pharmaceutical Technology Editors
As it investigates the root cause of an impurity discovered in valsartan, FDA extends its studies to APIs with similar synthesis processes.
Sep 02, 2018
Pharmaceutical Technology
The European Commission’s proposed amendment on SPC waivers has sparked opposing views from drug originators and producers of generic drugs and biosimilars.
Aug 17, 2018
By Pharmaceutical Technology Editors
FDA approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector.
Jul 19, 2018
In launching FDA’s Biosimilar Action Plan, Gottlieb takes innovator companies to task for delaying competitive biosimilar products.
native1_300x100
lorem ipsum